| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |